Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study

BACKGROUND: To assess the prognostic value of progesterone receptor (PR) expression in patients with hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer subgroups. METHODS: A retrospective review of breast cancer patients who underwent mastectomy or b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Sun, Jia-Yuan, Wu, San-Gang, Li, Feng-Yan, Lin, Huan-Xin, He, Zhen-Yu
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4807933/
https://ncbi.nlm.nih.gov/pubmed/27051305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S98666
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados